Seventeen patients diagnosed with Guillain-Barré Syndrome (GBS) are currently receiving treatment at Government General Hospitals (GGHs) ac ...

A trial of Moderna’s norovirus vaccine in the U.S. has been put on hold by the FDA over a reported case of neurological ...

Pune: The civic body has served notices to around 25 private RO water treatment plants to stop operations and decided to soon ...

The lack of data evaluating the clinical manifestations of adverse drug reactions before and during pregnancy shows need for more research in this area for this patient population, according to Ruchi ...

Jaishankar vows action against human traffickers in U.S. deportation case; Sheikh Hasina accuses Bangladesh government; Army ...

Hansa Biopharma AB, Hansa or the Company today announced its full year and Q4 2024 financial results. Søren Tulstrup, President and CEO, Hansa Biopharma said, "2024 proved to be a transformative year ...

IDEFIRIX Product Sales Increased 83% Compared to the Prior Year LUND, Sweden, Feb. 6, 2025 /PRNewswire/ -- Hansa Biopharma AB, Hansa or the Company (Nasdaq Stockholm: HNSA) today announced ...

FDA 2025 pulmonology drug alerts, including drug approvals/warnings, vaccine approvals, and medical device recalls/updates.

Nitin Narain, a survivor of Guillain-Barre Syndrome (GBS), recounts his harrowing experience with the disease and his long ...

The Food and Drug Administration (FDA) Maharashtra State had directed the Pune Municipal Corporation (PMC) for the testing of ...